EPZICOM
- Product NDC
- 70518-0691
- 11-digit product format
- 705180691
- Labeler code
- 70518
- Product ID
- 70518-0691_8ac4e1be-8d76-a66f-e053-2a95a90a097f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- abacavir sulfate and lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA021652
- Marketing category
- NDA
- Marketing start
- 2017-08-17
- Marketing end
- 0000-00-00
- Substance
- ABACAVIR SULFATE; LAMIVUDINE
- Active strength
- 600 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record